NCT06255249View on ClinicalTrials.gov

Multicenter Evaluation in Patients With MEningiomas of the Response to Treatment With 177LUTEtium-oxodotreotide

CompletedOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

October 30, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

March 30, 2025

Conditions

Meningioma

Trial Locations (1)

54511

CHRU of NANCY, Vandœuvre-lès-Nancy

All Listed Sponsors

lead

Central Hospital, Nancy, France

OTHER